HPSE and neoplasm: Moreover, as observed in human tumor cultures, in order to access tumor sites and exert antitumor effects, CAR T cells must be able to degrade heparan sulphate proteoglycans (HSPGs) by releasing specific enzymes, such as heparanase (HPSE) in the TME to reach their target [28,29].